What is it?
What this L-Arginine page covers
2This page covers plain L-arginine powders, capsules, and tablets. L-arginine hydrochloride, AAKG, L-citrulline, and multi-ingredient pre-workouts need separate form and active-gram comparison rather than being considered identical products.
Names, aliases and forms
Mechanisms of action
A proteinogenic amino acid
1L-arginine is the physiologically active L-isomer of arginine and a proteinogenic amino acid. It is present in food and synthesized in the body; its normal biological roles are not proof that extra oral intake improves performance or cognition.
Nitric oxide precursor, not a guaranteed pump
2Nitric oxide synthase can use L-arginine to produce nitric oxide, which participates in vascular tone. Oral exposure, baseline status, metabolism, and training context all limit how confidently that pathway can be translated into a visible pump, endurance, or recovery outcome.
Oral exposure is limited and variable
4In ten healthy volunteers, a single oral 10 g dose had approximately 20% absolute bioavailability. This helps explain why gram amounts and chemical form matter, but it is not a reason to increase the dose.
Potential effects and evidence map
L-arginine is a well-characterized nitric-oxide substrate, but supplement outcomes depend on endpoint and population. NIH ODS finds little to no consistent exercise benefit. A 2022 meta-analysis found a measurable blood-pressure-lowering effect across randomized trials, and condition-specific meta-analysis suggests possible benefit in mild to moderate erectile dysfunction. These vascular findings do not establish a general nootropic, pump, endurance, libido, or testosterone effect.
Exercise-performance evidence is limited and conflicting, with little to no reliable benefit across many anaerobic and aerobic studies.
Condition-specific trials suggest possible benefit for mild to moderate erectile dysfunction, but this is not a general libido, vitality, or testosterone effect.
No reliable direct focus or attention improvement has been established for plain L-arginine in healthy adults.
Typical dosages and timing
Use this range as a product-listing comparison, not a personalized target. NIH ODS reports exercise studies from 2-20 g/day and short-term tolerability up to 9 g/day, while higher study doses should not be normalized into routine use.
NIH ODS reports that GI discomfort and slight blood-pressure reduction are more common at 9-30 g/day. The healthy-adult safety review estimated a 7.531 g no-observed-adverse-effect level for a single dose; this is a research estimate, not an intake recommendation.
Compare the amount of actual L-arginine, not scoop size, capsule count, or total blend mass. Salt forms and AAKG should not be priced as though every gram were a gram of free-form L-arginine.
Blood-pressure, erectile-function, and post-heart-attack trials studied defined clinical populations. Their doses should not be copied into personal dosing or general-wellness instructions.
Timing & effect horizon
A single oral 10 g dose reached peak plasma L-arginine concentration at about one hour in healthy volunteers. This is a blood-level marker, not a reliable time-to-pump, focus, or performance benefit.
NIH ODS notes that many athlete studies lasted 1-28 days and still found little to no consistent effect on nitric oxide, blood flow, exercise metabolites, or performance. This is the intervention-duration range in those studies, not a recommended cycle.
The 2023 healthy-adult safety review covered randomized trials lasting 1-84 days. This is the duration range represented in the safety evidence, not a suggested course of use, and it does not establish indefinite high-dose safety.
The VINTAGE MI trial used 3 g three times daily for six months after acute myocardial infarction. Its harm signal is a specific recent-heart-attack warning, not evidence that healthy users face the same risk.
Safety, side effects and risk profile
Mild nausea, abdominal discomfort, bloating, or diarrhea can occur, especially with larger single or daily amounts.
L-arginine can lower blood pressure, but this is not usually harmful in healthy adults; low blood pressure, recent myocardial infarction, and vasodilating drug combinations are separate caution contexts.
Headache or lightheadedness is possible, particularly when blood pressure falls or L-arginine is combined with other vasodilating products.
Pregnancy-specific clinical protocols do not establish general supplement self-use safety, and lactation guidance is insufficient.
Across 34 double-blind randomized trials in healthy people, oral L-arginine did not significantly increase reported GI symptoms overall. Together with the NIH ODS short-term assessment, this supports minimal overall risk for ordinary use while preserving dose- and person-specific cautions.
Nausea, abdominal discomfort, bloating, or diarrhea can occur, especially with larger single or daily amounts. These effects are generally mild and reversible but can make high-dose powders impractical.
A 22-trial meta-analysis found average reductions in systolic and diastolic blood pressure, with a dose-response signal beginning around 4 g/day for systolic pressure. In otherwise healthy adults this physiological effect is not automatically harmful, but it matters for low baseline blood pressure and blood-pressure-lowering combinations.
Get individualized review before combining L-arginine with nitrates, blood-pressure drugs, sildenafil or similar PDE5 drugs, anticoagulant or antiplatelet products, glucose-lowering drugs, or potassium-sparing diuretics. Several combinations can compound low blood pressure, bleeding, glucose, or potassium concerns.
Although L-arginine has been studied in pregnancy-specific clinical settings, those protocols do not establish over-the-counter self-use safety or dosing. Pregnancy and lactation use should remain clinician-directed.
Mayo Clinic notes possible allergic response, airway inflammation, or worsening asthma symptoms. People with relevant histories should not regard a generally low headline tier as proof of individual suitability.
Legal and regulatory status
As of 2026, U.S. dietary-supplement structure/function claims must be substantiated, truthful, and not misleading. When applicable, claim-makers must provide FDA notification and the statutory disclaimer. Disease-specific claims can subject a product to drug requirements.
As of 2026, EFSA has evaluated multiple proposed L-arginine health claims. Authorization status and conditions must be checked claim by claim in the European Commission register; nitric-oxide biology alone does not authorize a broad performance, blood-pressure, or sexual-function claim.
This page does not establish classification or allowable claims outside the United States and European Union. Verify current country-specific rules and product classification before drawing a regulatory conclusion.
How it compares
L-arginine hydrochloride includes hydrochloride salt mass. Compare the label-declared L-arginine amount when available rather than assuming gram-for-gram equivalence with free-form base powder.
Arginine alpha-ketoglutarate combines arginine with alpha-ketoglutarate. It belongs in a separate form comparison and should not be counted as plain L-arginine gram for gram.
L-citrulline can contribute to arginine metabolism but is a distinct ingredient with separate dosing and evidence. Product cards and price comparisons should not consider the two names interchangeable.
Practical buying and quality notes
- Compare powders by price per gram of declared L-arginine after shipping and discounts. For capsules, calculate total active grams per container; for blends, exclude caffeine, creatine, citrulline, flavoring, and proprietary-matrix weight.2
- Single-ingredient evidence cannot predict a multi-ingredient formula. Check whether the label discloses each active amount and avoid assuming that a nitric-oxide blend has the same evidence or safety profile as plain L-arginine.2
- Look for a batch-specific certificate of analysis, amino-acid identity and purity testing, microbial and heavy-metal results, and independent sport certification when relevant. Certification supports label confidence but does not prove efficacy.2
FAQ
Does L-arginine work as a nootropic?
12No reliable direct focus, memory, or mental-performance effect has been established for plain L-arginine in healthy adults. A study of an inositol-stabilized arginine silicate mixture is not direct evidence for plain L-arginine.
Does L-arginine improve workout performance?
2NIH ODS summarizes the evidence as limited and conflicting, with little to no effect across many anaerobic and aerobic studies. A pump mechanism should not be presented as reliable strength, endurance, or recovery benefit.
What dose should product listings make easy to compare?
2A range covering 2 to 9 grams daily is useful for comparing labels and short-term safety context, not for choosing a personal dose. Larger trial amounts can produce more GI discomfort and blood-pressure change.
Can L-arginine lower blood pressure?
5Yes, randomized-trial meta-analysis shows a measurable average lowering effect. That does not establish an over-the-counter product for blood-pressure management, and it is the main reason low blood pressure and blood-pressure-lowering combinations require caution.
Who should avoid self-use?
6People with a recent heart attack should not self-use L-arginine. Clinical review is also important with low blood pressure, cardiovascular disease, the drug combinations listed above, pregnancy or lactation, and asthma or serious allergy history.
Is L-arginine the same as AAKG or L-citrulline?
2No. AAKG is a combination form and L-citrulline is a different amino acid. Compare active mass, evidence, and safety separately rather than considering the names interchangeable.
Is L-arginine safe?
3For generally healthy adults using ordinary short-term oral amounts, L-arginine fits a minimal-risk profile. Mild GI effects remain possible, while the important recent-heart-attack and drug-combination warnings apply to specific higher-risk contexts rather than the baseline user.
References
- National Center for Biotechnology Information. PubChem Compound Summary for CID 6322, L-Arginine.
- NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals.
- Kuramochi Y, Murata M, Sumino A, Sone H, Hayamizu K. Safety assessment of L-Arg oral intake in healthy subjects: a systematic review of randomized control trials. Amino Acids. 2023;55(12):1949-1964.
- Tangphao O, Grossmann M, Chalon S, Hoffman BB, Blaschke TF. Pharmacokinetics of intravenous and oral L-arginine in normal volunteers. Br J Clin Pharmacol. 1999;47(3):261-266.
- Shiraseb F, Asbaghi O, Bagheri R, et al. Effect of L-Arginine Supplementation on Blood Pressure in Adults: A Systematic Review and Dose-Response Meta-analysis of Randomized Clinical Trials. Adv Nutr. 2022;13(4):1226-1242.
- Schulman SP, Becker LC, Kass DA, et al. L-arginine therapy in acute myocardial infarction: the VINTAGE MI randomized clinical trial. JAMA. 2006;295(1):58-64.
- Rhim HC, Kim MS, Park YJ, et al. The Potential Role of Arginine Supplements on Erectile Dysfunction: A Systematic Review and Meta-Analysis. J Sex Med. 2019;16(2):223-234.
- Mayo Clinic. L-arginine.
- U.S. Food and Drug Administration. Structure/Function Claims.
- EFSA NDA Panel. Scientific Opinion on the substantiation of health claims related to L-arginine. EFSA Journal. 2011;9(4):2051.
- European Commission. EU Register of Health Claims.
- Kalman D, Harvey PD, Perez Ojalvo S, Komorowski J. Randomized Prospective Double-Blind Studies to Evaluate the Cognitive Effects of Inositol-Stabilized Arginine Silicate in Healthy Physically Active Adults. Nutrients. 2016;8(11):736.